Mini-Oral Abstract: Infections and vaccines
Saturday September 20, 2025 from 10:00 to 11:00
MOA 5
Moderators
Lectures
-
306.1 Clinical Outcomes of Switching from Tacrolimus to Cyclosporine A in Pediatric Kidney Transplant Recipients with BK Virus InfectionDr. Jianming Li, People's Republic of China
-
306.2 Lymphoproliferative Disease in kidney transplanted children: A single center experience from ArgentinaDr. Gabriela Gutièrrez, Argentina
-
306.3 Faecal microbiota transplantation for recurrent Clostridium difficile infection in paediatric kidney transplantationProf. Stephen D Marks, United Kingdom
-
306.4 Impact of pre-transplant anti-CD20 antibody administration on post-transplant EBV infection after pediatric liver transplantationDr. Koushin Kuroki, Japan
-
306.5 Incidence of EBV DNAemia among pediatric kidney transplant recipients in the COVID eraMrs. JoAnn M Morey, United States
-
306.6 Symptomatic urinary tract infections in children post kidney transplantationSiah Kim, Australia
-
306.7 Strategies for improving influenza vaccination rates in pediatric transplant recipientsMrs. Lindsey B Shinn, United States
-
306.8 A Colchicine-resistant FMF pediatric patient successfully treated with IL-1 antagonists after kidney transplantationEsra Baskin, Turkey